Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice

Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice

Introduction Phase 3 trials have shown comparable efficacy of direct oral anticoagulants (DOACs) and vitamin K antagonists in patients with acute venous thromboembolism (VTE), with less major bleeding events in patients randomized to DOAC treatment. With DOACs being increasingly used in clinical pra...

Full description

Bibliographic Details
Main Authors: Stephan V. Hendriks, Frederikus A. Klok, Wilhelmina J.E. Stenger, Albert T.A. Mairuhu, Jeroen Eikenboom, Jaap Fogteloo, Menno V. Huisman
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2020-04-01
Series:TH Open
Subjects:
apixaban
direct oral anticoagulants
safety
efficacy
venous thromboembolism
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1713683

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1713683

Similar Items